Enjoy complimentary customisation on priority with our Enterprise License!
The single cell analysis market share is expected to increase by USD 3.16 billion from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 0.05%.
The report also offers information on several players, including 10X Genomics Inc., Agilent Technologies Inc., Becton Dickinson and Co., Bio Rad Laboratories Inc., Bio Techne Corp., CellChorus Inc., DiaSorin SpA, Fluidigm Corp., Illumina Inc., NanoString Technologies Inc., QIAGEN NV, RareCyte Inc, Takara Bio Inc., Thermo Fisher Scientific Inc., Yokogawa Electric Corp., Danaher Corp., Merck KGaA, and Sartorius AG among others.
Download the Free Report Sample to Unlock the Market Size for the Forecast Period and Other Important Statistics
The increasing prevalence of cancer is notably driving the growth, although factors such as the high cost of these products may impede the growth.
Key Driver
One of the key factors driving the market is the increasing prevalence of cancer and the growth in cancer research. This can identify the mutation rates and determine DNA content and proliferation conditions of tumor cells found in cancer patients. The growing number of cancer cases in regions worldwide has resulted in an increased need for research to diagnose and treat cancer. The usage of this in cancer research has led to a better understanding of the biological characteristics of cancer lesions. Single-cell analysis based on NGS has progressed rapidly in recent years. It has various added advantages over other sequencing technologies to understand malignant tumor cells and immune cells. The increasing prevalence of cancer and growth in cancer research to study and evaluate tumor cells has led to diagnostic and therapeutic treatment options for cancer. This has led to an increased demand for consumables and instruments, which, in turn, is expected to drive the global market.
The increasing prevalence of chronic diseases, such as cancer, among individuals is another factor supporting the share. The incidence of genetic disorders is gradually increasing. The rising incidence of chronic diseases and genetic disorders leads researchers and scientists to opt for these consumables and instruments for diagnosing and treating patients. This is expected to drive the market.
The budget constraints while procuring testing instruments for medium- and small-scale testing laboratories and research institutes will be a major challenge during the forecast period. Affordability is a major concern in developing regions as emerging economies have many small- and medium-scale laboratories and research institutes with limited budgets. They prefer to partner with other institutions to conduct their research activities. Traditionally, individual labs do not have large, complex, and expensive mass spectrometers often found only in university laboratory facilities. Researchers in such labs send their samples to external laboratories for analysis or collaborate with proteomics specialists, who can process the samples for them. While these collaborative experiments may work, there is a high chance that they could lead to errors or misinterpreted results. New research laboratories cannot meet the funding requirements even from research grants, and therefore, the research effort required for a full-scale research program diminishes. This will negatively impact the adoption of testing products. The expensive nature of these tests leads to their decreased adoption among individuals, thereby reducing the overall demand for consumables and instruments necessary to perform these tests.
This report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the growth. The actionable insights on the trends and challenges will help companies evaluate and develop strategies for 2022-2026.
The report analyzes the market's competitive landscape and offers information on several market players, including:
This statistical study of the market encompasses successful business strategies deployed by the key companies. The market is fragmented and the companies are deploying strategies such as continuously innovating their offerings and building capabilities with less service differentiation to compete in the market.
To make the most of the opportunities and recover from post COVID-19 impact, market companies should focus more on the prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.
The market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.
Our report provides extensive information on the value chain analysis for the market, which companies can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chains is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help companies drive costs and enhance customer services during the forecast period.
The value chain of the healthcare equipment market includes the following core components:
The market research and growth report has further elucidated on other innovative approaches being followed by manufacturers to ensure a sustainable market presence.
For more insights on the market share of various regions Request for a FREE sample now!
45% of the market's growth will originate from North America during the forecast period. US and Canada are the key markets in North America. The market in this region will be faster than the growth of the market in the European and ROW regions.
The presence of prominent companies in the US and the increasing incidence of cancer will facilitate market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for companies, which will assist in creating efficient business plans.
To gain further insights on the market contribution of various segments Request for a FREE sample
The market share by the consumables segment will be significant during the forecast period. This market segment can be attributed to the increasing investments in purchasing consumables for single cell analysis. These consumables can be used for a wide range of research and diagnosis applications such as cancer, immunology, neurology stem cell research, non-invasive prenatal diagnosis, and tumor cell detection, among others. The availability of a wide range of consumables offers greater analysis in terms of a higher resolution of detection. Additionally, innovations and new product launches from companies are some of the key factors that will support the growth of the consumables segment of the global market during the forecast period.
The market is witnessing significant growth, driven by advancements in Single-cell sequencing technologies and techniques like Single-cell transcriptomics, In Situ Hybridization, Fluorescence-based detection devices, and Mass spectroscopy. These technologies enable the study of individual cells, providing insights into genetic complements, proteins, metabolomics, and small molecules. With applications in personalized medicine and research, the market is propelled by continuous technological advancements in the field of single-cell biology.
Key market players focus on innovative solutions, contributing to revenue generation through the development of consumables such as Beads, Reagents, Microplates, Assay Kits, Immunoassays, and other consumables. Medical applications like In Vitro Fertilization and Circulating Tumor Cell Detection, along with various research applications, drive demand. The consumables category and instruments section play crucial roles in catering to the diverse needs of the market. As the demand grows, companies invest in research and development to introduce cutting-edge solutions, fostering a dynamic market landscape. The market is further supported by the expansion of applications and the continuous evolution of technologies in the field.
Single Cell Analysis Market Scope |
|
Report Coverage |
Details |
Page number |
120 |
Base year |
2021 |
Forecast period |
2022-2026 |
Growth momentum & CAGR |
Accelerate at a CAGR of 0.05% |
Market Growth 2022-2026 |
USD 3.16 billion |
Market structure |
Fragmented |
YoY growth (%) |
2.55 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
North America at 45% |
Key consumer countries |
US, Canada, Germany, UK, and China |
Competitive landscape |
Leading companies, Competitive strategies, Consumer engagement scope |
Key companies profiled |
10X Genomics Inc., Agilent Technologies Inc., Becton Dickinson and Co., Bio Rad Laboratories Inc., Bio Techne Corp., CellChorus Inc., DiaSorin SpA, Fluidigm Corp., Illumina Inc., NanoString Technologies Inc., QIAGEN NV, RareCyte Inc, Takara Bio Inc., Thermo Fisher Scientific Inc., Yokogawa Electric Corp., Danaher Corp., Merck KGaA, and Sartorius AG |
Market dynamics |
Parent market analysis, Market forecasting, Market growth inducers and obstacles, market growth analysis, Fast-growing and slow-growing segment analysis, market trends and analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this report to meet your requirements. Get in touch
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Five Forces Analysis
5 Market Segmentation by Product
6 Customer Landscape
7 Geographic Landscape
8 Drivers, Challenges, and Trends
9 Vendor Landscape
10 Vendor Analysis
11 Appendix
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.